Massive cuts to personnel and funding within the Department of Health and Human Services presents a headache for vaccine approval and development, analysts say.
Moderna is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of cardiovascular and autoimmune diseases.